These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 15002036

  • 1. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine.
    Maeda H, Hori S, Ohizumi H, Segawa T, Kakehi Y, Ogawa O, Kakizuka A.
    Cell Death Differ; 2004 Jul; 11(7):737-46. PubMed ID: 15002036
    [Abstract] [Full Text] [Related]

  • 2. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 3. [Arsenic trioxide combined with buthionine sulfoximine enhances apoptosis in multidrug-resistant human leukemia K562/ADM cells in vitro].
    Wang T, Ma LM, Zhang HP, Wang HW, Yang LH, Qiao ZH.
    Zhonghua Zhong Liu Za Zhi; 2008 Mar 15; 30(3):188-91. PubMed ID: 18756933
    [Abstract] [Full Text] [Related]

  • 4. Differential augmentative effects of buthionine sulfoximine and ascorbic acid in As2O3-induced ovarian cancer cell death: oxidative stress-independent and -dependent cytotoxic potentiation.
    Ong PS, Chan SY, Ho PC.
    Int J Oncol; 2011 Jun 15; 38(6):1731-9. PubMed ID: 21455570
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
    Wu XX, Ogawa O, Kakehi Y.
    Int J Oncol; 2004 Jun 15; 24(6):1489-97. PubMed ID: 15138592
    [Abstract] [Full Text] [Related]

  • 6. Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
    Pu YS, Hour TC, Chen J, Huang CY, Guan JY, Lu SH.
    Urology; 2002 Aug 15; 60(2):346-50. PubMed ID: 12137851
    [Abstract] [Full Text] [Related]

  • 7. Induction of apoptosis in arsenic trioxide-treated lung cancer A549 cells by buthionine sulfoximine.
    Han YH, Kim SZ, Kim SH, Park WH.
    Mol Cells; 2008 Aug 31; 26(2):158-64. PubMed ID: 18596414
    [Abstract] [Full Text] [Related]

  • 8. [Study on the resveratrol and arsenic trioxide combination induced apoptosis and its mechanism on lung adenocarcinoma cells].
    Gu S, Chen C, Jiang X, Zhang Z.
    Wei Sheng Yan Jiu; 2016 Jan 31; 45(1):87-92. PubMed ID: 26987203
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 10. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells.
    Wirtitsch M, Roth E, Bachleitner-Hofmann T, Wessner B, Sturlan S.
    Oncol Res; 2009 Mar 08; 18(2-3):83-94. PubMed ID: 20066898
    [Abstract] [Full Text] [Related]

  • 11. [The effect of arsenic trioxide (As2O3) combined with BSO on K562/ADM cell and its mechanisms].
    Wang T, Ma LM, Zhang HP, Wang HW, Yang LH, Qiao ZH.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul 08; 28(7):438-43. PubMed ID: 18072624
    [Abstract] [Full Text] [Related]

  • 12. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T, Urasaki Y, Takemura H, Ueda T.
    Anticancer Res; 2005 Jul 08; 25(2A):991-8. PubMed ID: 15868938
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations.
    Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z, Chen GQ.
    J Natl Cancer Inst; 1999 May 05; 91(9):772-8. PubMed ID: 10328107
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of arsenic trioxide-mediated apoptosis using docosahexaenoic acid in arsenic trioxide-resistant solid tumor cells.
    Baumgartner M, Sturlan S, Roth E, Wessner B, Bachleitner-Hofmann T.
    Int J Cancer; 2004 Nov 20; 112(4):707-12. PubMed ID: 15382055
    [Abstract] [Full Text] [Related]

  • 15. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M, Stańczyk M, Czyz M, Stepnik M.
    Cancer Chemother Pharmacol; 2008 Apr 20; 61(5):727-37. PubMed ID: 17594095
    [Abstract] [Full Text] [Related]

  • 16. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
    You BR, Park WH.
    Oncol Rep; 2012 Aug 20; 28(2):749-57. PubMed ID: 22684917
    [Abstract] [Full Text] [Related]

  • 17. Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
    Zhao XY, Yang S, Chen YR, Li PC, Dou MM, Zhang J.
    PLoS One; 2014 Aug 20; 9(6):e98925. PubMed ID: 24901647
    [Abstract] [Full Text] [Related]

  • 18. [Glutathione synthesis inhibitor enhances arsenic trioxide-induced apoptosis].
    Shen Y, Chen G, Cai X.
    Zhonghua Zhong Liu Za Zhi; 1999 Jul 20; 21(4):259-61. PubMed ID: 11776809
    [Abstract] [Full Text] [Related]

  • 19. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
    Zhou Y, Huang X, Cai X.
    Zhonghua Zhong Liu Za Zhi; 2001 May 20; 23(3):181-3. PubMed ID: 11783079
    [Abstract] [Full Text] [Related]

  • 20. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis.
    Kitamura K, Minami Y, Yamamoto K, Akao Y, Kiyoi H, Saito H, Naoe T.
    Leukemia; 2000 Oct 20; 14(10):1743-50. PubMed ID: 11021749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.